Matches in SemOpenAlex for { <https://semopenalex.org/work/W3124636175> ?p ?o ?g. }
- W3124636175 abstract "Objective: This study was conducted to evaluate the potential genetic and non-genetic factors contributing to plasma trough concentration-to-dose ( C 0 / D ) ratio of valproic acid (VPA) in pediatric patients with epilepsy. Study Design: A single-center, retrospective cohort study was performed by collecting data from 194 children aged 1–14 years between May 2018 and November 2018. The oral solution ( n = 135) group and the sustained-release (SR) tablet group ( n = 59) were defined, and the plasma VPA C 0 was measured. Twenty-six single-nucleotide polymorphisms (SNPs) were chosen for genotyping with the MassARRAY system. A multiple logistic regression model was used for data analysis. Results: Body weight (BW) and age were positively correlated with the C 0 / D ratio in 194 patients, but the positive correlation disappeared after the patients were divided into oral solution and SR tablet subgroups. The average C 0 / D ratio was significantly increased by 2.11-fold ( P = 0.000) in children who took VPA SR tablets compared with children who were administered VPA oral solutions. No significant association between genetic variants and the C 0 / D ratio was found, even for the five well-studied SNPs, namely UGT2B7 G211T, C802T, C161T, T125C, and CYP2C9 * 3 A1075C. However, a significant association between the C 0 / D ratio and UGT1A6/9 Del>A (rs144486213) was observed in the VPA oral solution group, but not in the VPA SR tablet group. Conclusions: The dosage forms of sodium valproate, rather than BW, age, or genetic polymorphisms, significantly affected the VPA C 0 / D ratios in pediatric patients with epilepsy. Based on our findings, switching the dosage form between solution and SR tablet should be performed cautiously. Total daily dose adjustment should be considered, and the plasma concentration, seizure-control effect, and adverse drug reaction should also be monitored very closely." @default.
- W3124636175 created "2021-02-01" @default.
- W3124636175 creator A5007268989 @default.
- W3124636175 creator A5042187700 @default.
- W3124636175 creator A5042618679 @default.
- W3124636175 creator A5046091459 @default.
- W3124636175 creator A5052987214 @default.
- W3124636175 creator A5053204257 @default.
- W3124636175 creator A5060148518 @default.
- W3124636175 creator A5072861069 @default.
- W3124636175 creator A5077260323 @default.
- W3124636175 creator A5090232730 @default.
- W3124636175 creator A5091472243 @default.
- W3124636175 date "2021-01-20" @default.
- W3124636175 modified "2023-10-13" @default.
- W3124636175 title "Genetic and Non-genetic Factors Contributing to the Significant Variation in the Plasma Trough Concentration-to-Dose Ratio of Valproic Acid in Children With Epilepsy" @default.
- W3124636175 cites W1178726026 @default.
- W3124636175 cites W1545701877 @default.
- W3124636175 cites W1749955190 @default.
- W3124636175 cites W1969672346 @default.
- W3124636175 cites W1982677579 @default.
- W3124636175 cites W2001689479 @default.
- W3124636175 cites W2017976932 @default.
- W3124636175 cites W2060587811 @default.
- W3124636175 cites W2070579660 @default.
- W3124636175 cites W2082501248 @default.
- W3124636175 cites W2092021916 @default.
- W3124636175 cites W2117039119 @default.
- W3124636175 cites W2123276946 @default.
- W3124636175 cites W2125413295 @default.
- W3124636175 cites W2126332685 @default.
- W3124636175 cites W2146159727 @default.
- W3124636175 cites W2154447677 @default.
- W3124636175 cites W2171987398 @default.
- W3124636175 cites W2186105609 @default.
- W3124636175 cites W2265770402 @default.
- W3124636175 cites W2399856487 @default.
- W3124636175 cites W2415511108 @default.
- W3124636175 cites W2460792713 @default.
- W3124636175 cites W2461355871 @default.
- W3124636175 cites W2541762347 @default.
- W3124636175 cites W2593772135 @default.
- W3124636175 cites W2773107542 @default.
- W3124636175 cites W2779604619 @default.
- W3124636175 cites W2798248858 @default.
- W3124636175 cites W2800645861 @default.
- W3124636175 cites W2914183510 @default.
- W3124636175 cites W2922074526 @default.
- W3124636175 cites W2927322282 @default.
- W3124636175 cites W2933327741 @default.
- W3124636175 cites W2938570370 @default.
- W3124636175 cites W2961503558 @default.
- W3124636175 cites W2972367557 @default.
- W3124636175 cites W2988529192 @default.
- W3124636175 doi "https://doi.org/10.3389/fped.2020.599044" @default.
- W3124636175 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7855978" @default.
- W3124636175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33553069" @default.
- W3124636175 hasPublicationYear "2021" @default.
- W3124636175 type Work @default.
- W3124636175 sameAs 3124636175 @default.
- W3124636175 citedByCount "4" @default.
- W3124636175 countsByYear W31246361752021 @default.
- W3124636175 countsByYear W31246361752022 @default.
- W3124636175 countsByYear W31246361752023 @default.
- W3124636175 crossrefType "journal-article" @default.
- W3124636175 hasAuthorship W3124636175A5007268989 @default.
- W3124636175 hasAuthorship W3124636175A5042187700 @default.
- W3124636175 hasAuthorship W3124636175A5042618679 @default.
- W3124636175 hasAuthorship W3124636175A5046091459 @default.
- W3124636175 hasAuthorship W3124636175A5052987214 @default.
- W3124636175 hasAuthorship W3124636175A5053204257 @default.
- W3124636175 hasAuthorship W3124636175A5060148518 @default.
- W3124636175 hasAuthorship W3124636175A5072861069 @default.
- W3124636175 hasAuthorship W3124636175A5077260323 @default.
- W3124636175 hasAuthorship W3124636175A5090232730 @default.
- W3124636175 hasAuthorship W3124636175A5091472243 @default.
- W3124636175 hasBestOaLocation W31246361751 @default.
- W3124636175 hasConcept C104317684 @default.
- W3124636175 hasConcept C112705442 @default.
- W3124636175 hasConcept C118552586 @default.
- W3124636175 hasConcept C126322002 @default.
- W3124636175 hasConcept C135763542 @default.
- W3124636175 hasConcept C153209595 @default.
- W3124636175 hasConcept C2777172819 @default.
- W3124636175 hasConcept C2778186239 @default.
- W3124636175 hasConcept C2780272996 @default.
- W3124636175 hasConcept C2910800852 @default.
- W3124636175 hasConcept C31467283 @default.
- W3124636175 hasConcept C3946865 @default.
- W3124636175 hasConcept C526171541 @default.
- W3124636175 hasConcept C54355233 @default.
- W3124636175 hasConcept C62231903 @default.
- W3124636175 hasConcept C71924100 @default.
- W3124636175 hasConcept C86803240 @default.
- W3124636175 hasConcept C90924648 @default.
- W3124636175 hasConceptScore W3124636175C104317684 @default.
- W3124636175 hasConceptScore W3124636175C112705442 @default.
- W3124636175 hasConceptScore W3124636175C118552586 @default.
- W3124636175 hasConceptScore W3124636175C126322002 @default.
- W3124636175 hasConceptScore W3124636175C135763542 @default.